Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
57.27
+0.12 (0.20%)
Dec 30, 2025, 11:33 AM EST - Market open
Utah Medical Products Revenue
Utah Medical Products had revenue of $9.81M in the quarter ending September 30, 2025, a decrease of -1.93%. This brings the company's revenue in the last twelve months to $38.63M, down -12.35% year-over-year. In the year 2024, Utah Medical Products had annual revenue of $40.90M, down -18.56%.
Revenue (ttm)
$38.63M
Revenue Growth
-12.35%
P/S Ratio
4.86
Revenue / Employee
$231,335
Employees
167
Market Cap
183.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40.90M | -9.32M | -18.56% |
| Dec 31, 2023 | 50.22M | -2.06M | -3.93% |
| Dec 31, 2022 | 52.28M | 3.23M | 6.58% |
| Dec 31, 2021 | 49.05M | 6.88M | 16.30% |
| Dec 31, 2020 | 42.18M | -4.73M | -10.08% |
| Dec 31, 2019 | 46.90M | 4.91M | 11.68% |
| Dec 31, 2018 | 42.00M | 584.00K | 1.41% |
| Dec 31, 2017 | 41.41M | 2.12M | 5.38% |
| Dec 31, 2016 | 39.30M | -859.00K | -2.14% |
| Dec 31, 2015 | 40.16M | -1.12M | -2.72% |
| Dec 31, 2014 | 41.28M | 785.00K | 1.94% |
| Dec 31, 2013 | 40.49M | -1.06M | -2.55% |
| Dec 31, 2012 | 41.55M | 3.69M | 9.75% |
| Dec 31, 2011 | 37.86M | 12.74M | 50.71% |
| Dec 31, 2010 | 25.12M | -795.00K | -3.07% |
| Dec 31, 2009 | 25.92M | -1.87M | -6.72% |
| Dec 31, 2008 | 27.78M | -720.00K | -2.53% |
| Dec 31, 2007 | 28.50M | -251.00K | -0.87% |
| Dec 31, 2006 | 28.75M | 1.06M | 3.83% |
| Dec 31, 2005 | 27.69M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
UTMD News
- 2 months ago - Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend - Accesswire
- 2 months ago - UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025 - Accesswire
- 5 months ago - Utah Medical Products, Inc. Announces Quarterly Dividend - Accesswire
- 5 months ago - UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2025 - Accesswire
- 6 months ago - Utah Medical Products: Deep Discount Is Drawing One Legendary Investor's Interest - Seeking Alpha
- 8 months ago - Stock Picks From Seeking Alpha's April 2025 New Analysts - Seeking Alpha
- 8 months ago - Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2025 - Accesswire
- 9 months ago - Utah Medical Products: Quietly Profitable--A Deep Value Gem Hiding In The Open - Seeking Alpha